| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanoparticles | 19 | 2024 | 268 | 6.380 |
Why?
|
| Photochemotherapy | 7 | 2022 | 39 | 3.480 |
Why?
|
| Neoplasms | 16 | 2024 | 2853 | 2.860 |
Why?
|
| Hydrogen Peroxide | 7 | 2025 | 110 | 2.650 |
Why?
|
| Photosensitizing Agents | 5 | 2021 | 35 | 2.510 |
Why?
|
| Hydroxyl Radical | 6 | 2025 | 13 | 2.210 |
Why?
|
| Nanostructures | 7 | 2024 | 59 | 2.190 |
Why?
|
| Mammary Glands, Animal | 10 | 2025 | 446 | 2.170 |
Why?
|
| Antineoplastic Agents | 10 | 2021 | 1761 | 1.930 |
Why?
|
| Iron | 3 | 2025 | 300 | 1.870 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2025 | 237 | 1.860 |
Why?
|
| Metal-Organic Frameworks | 3 | 2025 | 6 | 1.660 |
Why?
|
| Ferrous Compounds | 3 | 2021 | 10 | 1.510 |
Why?
|
| Tumor Microenvironment | 7 | 2025 | 630 | 1.500 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2024 | 3717 | 1.390 |
Why?
|
| Mice | 45 | 2025 | 17704 | 1.380 |
Why?
|
| Zeolites | 2 | 2021 | 3 | 1.380 |
Why?
|
| Animals | 57 | 2025 | 33242 | 1.360 |
Why?
|
| Skin Neoplasms | 5 | 2023 | 874 | 1.300 |
Why?
|
| Breast Neoplasms | 13 | 2025 | 2586 | 1.290 |
Why?
|
| Liver Neoplasms | 4 | 2025 | 1350 | 1.280 |
Why?
|
| Cell Line, Tumor | 21 | 2024 | 3506 | 1.240 |
Why?
|
| Metal Nanoparticles | 4 | 2024 | 54 | 1.220 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 227 | 1.120 |
Why?
|
| Magnesium | 2 | 2024 | 119 | 1.050 |
Why?
|
| Gadolinium | 5 | 2020 | 110 | 1.000 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2025 | 967 | 0.950 |
Why?
|
| Cerium | 3 | 2024 | 8 | 0.950 |
Why?
|
| Cellular Senescence | 3 | 2024 | 200 | 0.930 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4444 | 0.930 |
Why?
|
| Lipid Droplets | 1 | 2025 | 51 | 0.920 |
Why?
|
| Free Radicals | 2 | 2024 | 33 | 0.880 |
Why?
|
| Alginates | 1 | 2024 | 23 | 0.880 |
Why?
|
| Gold | 1 | 2024 | 52 | 0.870 |
Why?
|
| Energy Transfer | 2 | 2024 | 17 | 0.860 |
Why?
|
| Melanoma, Experimental | 1 | 2024 | 37 | 0.860 |
Why?
|
| Optogenetics | 1 | 2024 | 67 | 0.860 |
Why?
|
| Cancer Pain | 1 | 2024 | 24 | 0.850 |
Why?
|
| Epithelial Cells | 8 | 2024 | 874 | 0.850 |
Why?
|
| Zinc | 1 | 2024 | 121 | 0.850 |
Why?
|
| Endopeptidases | 1 | 2024 | 108 | 0.850 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 45 | 0.850 |
Why?
|
| Tyrosine | 1 | 2024 | 146 | 0.840 |
Why?
|
| Genetic Vectors | 4 | 2020 | 893 | 0.830 |
Why?
|
| Carbon | 1 | 2024 | 88 | 0.830 |
Why?
|
| Hydrogels | 1 | 2024 | 95 | 0.820 |
Why?
|
| NF-kappa B | 2 | 2024 | 437 | 0.810 |
Why?
|
| Humans | 65 | 2025 | 127585 | 0.800 |
Why?
|
| Glutathione | 4 | 2023 | 195 | 0.790 |
Why?
|
| Immunotherapy | 2 | 2025 | 742 | 0.780 |
Why?
|
| Mammary Neoplasms, Animal | 4 | 2018 | 134 | 0.780 |
Why?
|
| Stem Cells | 4 | 2021 | 687 | 0.780 |
Why?
|
| Cysteine | 2 | 2020 | 137 | 0.770 |
Why?
|
| Keloid | 1 | 2022 | 11 | 0.770 |
Why?
|
| Apoptosis | 8 | 2024 | 1826 | 0.760 |
Why?
|
| Carcinogenesis | 6 | 2021 | 345 | 0.760 |
Why?
|
| Wound Infection | 1 | 2022 | 47 | 0.750 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2023 | 122 | 0.750 |
Why?
|
| Precancerous Conditions | 3 | 2023 | 278 | 0.750 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2022 | 7 | 0.740 |
Why?
|
| Melanoma | 4 | 2024 | 897 | 0.730 |
Why?
|
| Oncolytic Viruses | 1 | 2022 | 75 | 0.720 |
Why?
|
| Pseudopodia | 1 | 2021 | 7 | 0.720 |
Why?
|
| Autophagy | 2 | 2023 | 405 | 0.710 |
Why?
|
| Oncolytic Virotherapy | 1 | 2022 | 89 | 0.710 |
Why?
|
| Ferric Compounds | 2 | 2021 | 38 | 0.710 |
Why?
|
| Keratosis, Actinic | 1 | 2021 | 14 | 0.700 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 606 | 0.700 |
Why?
|
| Platinum | 1 | 2021 | 13 | 0.690 |
Why?
|
| Aminolevulinic Acid | 2 | 2021 | 9 | 0.690 |
Why?
|
| Cell Proliferation | 11 | 2024 | 2405 | 0.680 |
Why?
|
| Phosphotungstic Acid | 1 | 2020 | 1 | 0.680 |
Why?
|
| Glioma | 1 | 2025 | 480 | 0.680 |
Why?
|
| Tumor Hypoxia | 1 | 2020 | 5 | 0.680 |
Why?
|
| DNA, Catalytic | 1 | 2020 | 4 | 0.670 |
Why?
|
| Gene Editing | 1 | 2023 | 208 | 0.670 |
Why?
|
| Chlorine | 1 | 2020 | 15 | 0.670 |
Why?
|
| Neoplasms, Experimental | 3 | 2021 | 204 | 0.650 |
Why?
|
| Thermography | 1 | 2020 | 11 | 0.650 |
Why?
|
| Neurons | 3 | 2024 | 1911 | 0.640 |
Why?
|
| Wnt Signaling Pathway | 3 | 2021 | 199 | 0.630 |
Why?
|
| Imidazoles | 1 | 2021 | 218 | 0.630 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2019 | 5 | 0.610 |
Why?
|
| Oncogenes | 4 | 2024 | 162 | 0.610 |
Why?
|
| Brain Neoplasms | 3 | 2025 | 1236 | 0.610 |
Why?
|
| Transfection | 2 | 2020 | 955 | 0.600 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 98 | 0.600 |
Why?
|
| Cisplatin | 2 | 2018 | 269 | 0.600 |
Why?
|
| Lentivirus | 5 | 2020 | 80 | 0.600 |
Why?
|
| Silver Compounds | 1 | 2018 | 7 | 0.580 |
Why?
|
| Membrane Proteins | 2 | 2024 | 1564 | 0.570 |
Why?
|
| Prodrugs | 1 | 2018 | 53 | 0.570 |
Why?
|
| Oxygen | 2 | 2018 | 541 | 0.560 |
Why?
|
| Phosphates | 1 | 2018 | 107 | 0.560 |
Why?
|
| Contrast Media | 4 | 2024 | 461 | 0.550 |
Why?
|
| Rats | 5 | 2025 | 3396 | 0.550 |
Why?
|
| DNA Helicases | 1 | 2019 | 229 | 0.540 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 875 | 0.530 |
Why?
|
| Spinal Cord Injuries | 1 | 2020 | 273 | 0.530 |
Why?
|
| Nuclear Proteins | 3 | 2023 | 1206 | 0.510 |
Why?
|
| Keratin-6 | 4 | 2016 | 13 | 0.510 |
Why?
|
| Drug Screening Assays, Antitumor | 3 | 2021 | 106 | 0.510 |
Why?
|
| Surface Properties | 3 | 2021 | 80 | 0.510 |
Why?
|
| Particle Size | 3 | 2021 | 134 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 1933 | 0.500 |
Why?
|
| Catalysis | 3 | 2021 | 135 | 0.490 |
Why?
|
| Reactive Oxygen Species | 4 | 2024 | 495 | 0.470 |
Why?
|
| Cell Survival | 5 | 2021 | 841 | 0.470 |
Why?
|
| Keratoderma, Palmoplantar | 2 | 2025 | 6 | 0.450 |
Why?
|
| Gene Transfer Techniques | 2 | 2023 | 342 | 0.450 |
Why?
|
| Serpins | 2 | 2025 | 34 | 0.450 |
Why?
|
| Silicon Dioxide | 4 | 2020 | 31 | 0.440 |
Why?
|
| X-Rays | 3 | 2021 | 30 | 0.440 |
Why?
|
| Micelles | 2 | 2024 | 18 | 0.440 |
Why?
|
| Wound Healing | 3 | 2025 | 454 | 0.430 |
Why?
|
| Female | 38 | 2025 | 68803 | 0.420 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2516 | 0.420 |
Why?
|
| Oxidative Stress | 3 | 2024 | 761 | 0.420 |
Why?
|
| Boron Compounds | 2 | 2024 | 33 | 0.410 |
Why?
|
| Mice, Transgenic | 9 | 2023 | 2281 | 0.410 |
Why?
|
| Electrons | 3 | 2023 | 23 | 0.400 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1395 | 0.390 |
Why?
|
| Oxidation-Reduction | 4 | 2023 | 426 | 0.390 |
Why?
|
| Porphyrins | 2 | 2024 | 15 | 0.380 |
Why?
|
| Wnt Proteins | 1 | 2013 | 200 | 0.380 |
Why?
|
| Copper | 2 | 2025 | 72 | 0.380 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1494 | 0.360 |
Why?
|
| CRISPR-Cas Systems | 2 | 2025 | 286 | 0.350 |
Why?
|
| Infrared Rays | 2 | 2021 | 21 | 0.350 |
Why?
|
| Unemployment | 2 | 2021 | 23 | 0.340 |
Why?
|
| HeLa Cells | 4 | 2020 | 685 | 0.330 |
Why?
|
| Protein Array Analysis | 2 | 2022 | 107 | 0.320 |
Why?
|
| Retroviridae | 3 | 2023 | 182 | 0.320 |
Why?
|
| Magnetic Fields | 2 | 2021 | 7 | 0.310 |
Why?
|
| Transcription Factors | 1 | 2019 | 2346 | 0.310 |
Why?
|
| Cell Movement | 3 | 2022 | 855 | 0.290 |
Why?
|
| Phototherapy | 2 | 2022 | 36 | 0.290 |
Why?
|
| Methylmercury Compounds | 2 | 2018 | 4 | 0.280 |
Why?
|
| Seafood | 2 | 2018 | 10 | 0.270 |
Why?
|
| Mice, Nude | 5 | 2021 | 708 | 0.270 |
Why?
|
| Quality of Life | 3 | 2022 | 2031 | 0.260 |
Why?
|
| Nanotechnology | 2 | 2020 | 49 | 0.260 |
Why?
|
| Bone Neoplasms | 2 | 2024 | 430 | 0.250 |
Why?
|
| Mice, Inbred BALB C | 5 | 2021 | 1003 | 0.250 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 452 | 0.240 |
Why?
|
| Cell Plasticity | 2 | 2017 | 37 | 0.240 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2019 | 238 | 0.240 |
Why?
|
| Linoleic Acid | 1 | 2025 | 19 | 0.240 |
Why?
|
| Janus Kinase 2 | 2 | 2018 | 136 | 0.230 |
Why?
|
| beta Catenin | 3 | 2023 | 206 | 0.230 |
Why?
|
| Genes, Reporter | 4 | 2020 | 348 | 0.230 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 241 | 0.220 |
Why?
|
| Glycolysis | 2 | 2024 | 169 | 0.220 |
Why?
|
| Gelatinases | 1 | 2024 | 16 | 0.220 |
Why?
|
| Borohydrides | 1 | 2024 | 2 | 0.220 |
Why?
|
| Heterocyclic Compounds | 1 | 2024 | 18 | 0.220 |
Why?
|
| Electrodes | 1 | 2024 | 79 | 0.220 |
Why?
|
| Liver | 2 | 2024 | 1764 | 0.220 |
Why?
|
| China | 6 | 2021 | 277 | 0.220 |
Why?
|
| Signal Transduction | 8 | 2024 | 4490 | 0.220 |
Why?
|
| Melanins | 1 | 2024 | 16 | 0.220 |
Why?
|
| Motor Cortex | 1 | 2024 | 63 | 0.220 |
Why?
|
| Epidermis | 1 | 2024 | 63 | 0.210 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 110 | 0.210 |
Why?
|
| Analgesia | 1 | 2024 | 43 | 0.210 |
Why?
|
| Benzopyrans | 1 | 2024 | 22 | 0.210 |
Why?
|
| Light | 1 | 2024 | 167 | 0.210 |
Why?
|
| Electricity | 1 | 2023 | 9 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 1 | 2024 | 107 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 477 | 0.200 |
Why?
|
| Analgesics | 1 | 2024 | 120 | 0.200 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 17 | 0.200 |
Why?
|
| Male | 13 | 2025 | 62935 | 0.200 |
Why?
|
| Boron | 1 | 2022 | 2 | 0.200 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 2022 | 14 | 0.190 |
Why?
|
| Peptidoglycan | 1 | 2022 | 21 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2022 | 25 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2022 | 63 | 0.190 |
Why?
|
| Thiazoles | 1 | 2023 | 104 | 0.190 |
Why?
|
| Nanomedicine | 1 | 2022 | 27 | 0.190 |
Why?
|
| Microbubbles | 1 | 2022 | 8 | 0.190 |
Why?
|
| Fluorides | 2 | 2019 | 16 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 247 | 0.180 |
Why?
|
| Endometrial Neoplasms | 1 | 2023 | 108 | 0.180 |
Why?
|
| Acoustics | 1 | 2022 | 21 | 0.180 |
Why?
|
| Action Potentials | 1 | 2024 | 462 | 0.180 |
Why?
|
| Proteogenomics | 1 | 2023 | 107 | 0.180 |
Why?
|
| Electric Impedance | 1 | 2022 | 71 | 0.180 |
Why?
|
| Dermabrasion | 1 | 2021 | 3 | 0.180 |
Why?
|
| Neoplastic Stem Cells | 2 | 2014 | 329 | 0.180 |
Why?
|
| Drug Carriers | 2 | 2023 | 116 | 0.180 |
Why?
|
| Nitrosative Stress | 1 | 2021 | 3 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2024 | 1125 | 0.180 |
Why?
|
| Metformin | 1 | 2023 | 159 | 0.180 |
Why?
|
| Dietary Exposure | 2 | 2018 | 3 | 0.180 |
Why?
|
| Hydrogenation | 1 | 2021 | 3 | 0.180 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.170 |
Why?
|
| Oryza | 1 | 2021 | 30 | 0.170 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 291 | 0.170 |
Why?
|
| Metals, Heavy | 1 | 2021 | 23 | 0.170 |
Why?
|
| Cell Nucleus | 1 | 2023 | 553 | 0.170 |
Why?
|
| Lysosomes | 1 | 2023 | 247 | 0.170 |
Why?
|
| NAD | 1 | 2021 | 50 | 0.170 |
Why?
|
| Rats, Transgenic | 1 | 2020 | 17 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2022 | 330 | 0.170 |
Why?
|
| Fluorescence | 2 | 2018 | 97 | 0.170 |
Why?
|
| Receptors, Estrogen | 2 | 2021 | 714 | 0.170 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2020 | 25 | 0.170 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2020 | 11 | 0.170 |
Why?
|
| Silver | 1 | 2020 | 27 | 0.170 |
Why?
|
| Fibroblasts | 2 | 2022 | 834 | 0.160 |
Why?
|
| STAT5 Transcription Factor | 2 | 2018 | 85 | 0.160 |
Why?
|
| Sodium Fluoride | 1 | 2020 | 7 | 0.160 |
Why?
|
| Mixed Function Oxygenases | 1 | 2020 | 36 | 0.160 |
Why?
|
| Neuroprotection | 1 | 2020 | 30 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2022 | 414 | 0.160 |
Why?
|
| Metallocenes | 1 | 2020 | 2 | 0.160 |
Why?
|
| Adenoviridae | 1 | 2023 | 575 | 0.160 |
Why?
|
| Neoplasm Invasiveness | 2 | 2019 | 637 | 0.160 |
Why?
|
| HEK293 Cells | 2 | 2020 | 777 | 0.160 |
Why?
|
| Hyperthermia, Induced | 2 | 2018 | 53 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2020 | 59 | 0.160 |
Why?
|
| Spine | 1 | 2020 | 139 | 0.160 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 71 | 0.160 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 399 | 0.160 |
Why?
|
| Bismuth | 1 | 2020 | 83 | 0.160 |
Why?
|
| Calcium Carbonate | 1 | 2019 | 11 | 0.160 |
Why?
|
| Plasmids | 1 | 2020 | 452 | 0.150 |
Why?
|
| In Situ Hybridization | 1 | 2020 | 449 | 0.150 |
Why?
|
| Genomic Imprinting | 1 | 2020 | 127 | 0.150 |
Why?
|
| Sepsis | 1 | 2024 | 494 | 0.150 |
Why?
|
| Transplantation, Heterologous | 1 | 2020 | 255 | 0.150 |
Why?
|
| Theranostic Nanomedicine | 2 | 2017 | 8 | 0.150 |
Why?
|
| Temperature | 1 | 2020 | 289 | 0.150 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2020 | 153 | 0.150 |
Why?
|
| Ultrasonography | 1 | 2023 | 944 | 0.150 |
Why?
|
| Skin Diseases | 1 | 2020 | 138 | 0.150 |
Why?
|
| Polymers | 1 | 2020 | 111 | 0.150 |
Why?
|
| A549 Cells | 1 | 2018 | 49 | 0.150 |
Why?
|
| Bacteria | 1 | 2022 | 517 | 0.150 |
Why?
|
| Inflammation | 2 | 2024 | 1434 | 0.150 |
Why?
|
| Spleen | 1 | 2019 | 255 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 1426 | 0.150 |
Why?
|
| Juglandaceae | 1 | 2018 | 1 | 0.150 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 193 | 0.140 |
Why?
|
| Lithium Compounds | 1 | 2018 | 14 | 0.140 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2019 | 276 | 0.140 |
Why?
|
| Histones | 1 | 2022 | 503 | 0.140 |
Why?
|
| Wnt1 Protein | 1 | 2018 | 74 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2020 | 433 | 0.140 |
Why?
|
| Diptera | 1 | 2018 | 20 | 0.140 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1887 | 0.140 |
Why?
|
| Food Contamination | 1 | 2018 | 27 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2020 | 1893 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 4516 | 0.140 |
Why?
|
| Electrochemical Techniques | 1 | 2017 | 7 | 0.140 |
Why?
|
| Astacoidea | 1 | 2017 | 2 | 0.140 |
Why?
|
| Naphthoquinones | 1 | 2017 | 9 | 0.130 |
Why?
|
| Water Pollutants, Chemical | 1 | 2018 | 37 | 0.130 |
Why?
|
| Twist-Related Protein 1 | 1 | 2017 | 34 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 2049 | 0.130 |
Why?
|
| Middle Aged | 4 | 2024 | 27867 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 285 | 0.130 |
Why?
|
| Bone Density Conservation Agents | 1 | 2017 | 57 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2017 | 101 | 0.130 |
Why?
|
| Muscles | 1 | 2017 | 222 | 0.130 |
Why?
|
| Biosensing Techniques | 1 | 2017 | 70 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 590 | 0.130 |
Why?
|
| Homeostasis | 1 | 2020 | 692 | 0.120 |
Why?
|
| Polylysine | 1 | 2016 | 11 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 363 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 376 | 0.110 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 623 | 0.110 |
Why?
|
| Claudins | 1 | 2014 | 30 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 81 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2921 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2020 | 740 | 0.110 |
Why?
|
| Gene Expression Profiling | 2 | 2020 | 1775 | 0.110 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 902 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 204 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 158 | 0.110 |
Why?
|
| Tungsten Compounds | 1 | 2013 | 2 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
| Ischemia | 1 | 2017 | 342 | 0.110 |
Why?
|
| Blood Vessels | 1 | 2014 | 98 | 0.100 |
Why?
|
| Anxiety | 1 | 2020 | 965 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2022 | 17105 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2013 | 35 | 0.100 |
Why?
|
| Phosphorylation | 4 | 2024 | 1540 | 0.100 |
Why?
|
| Gene Amplification | 1 | 2014 | 228 | 0.100 |
Why?
|
| Adult | 5 | 2025 | 30609 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2016 | 335 | 0.100 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2012 | 12 | 0.100 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2019 | 426 | 0.100 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 217 | 0.090 |
Why?
|
| Molecular Imaging | 1 | 2013 | 60 | 0.090 |
Why?
|
| Thyroid Hormones | 1 | 2012 | 55 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2015 | 467 | 0.090 |
Why?
|
| Biomarkers, Tumor | 1 | 2020 | 1562 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2016 | 438 | 0.090 |
Why?
|
| Depression | 1 | 2020 | 1296 | 0.090 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 12 | 0.090 |
Why?
|
| ErbB Receptors | 1 | 2012 | 287 | 0.090 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2014 | 272 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 728 | 0.080 |
Why?
|
| Chromatin | 2 | 2023 | 472 | 0.080 |
Why?
|
| I-kappa B Kinase | 2 | 2024 | 56 | 0.080 |
Why?
|
| Mice, Knockout | 4 | 2024 | 3731 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2014 | 361 | 0.070 |
Why?
|
| Brain | 2 | 2017 | 3037 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 777 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2008 | 84 | 0.070 |
Why?
|
| Treatment Outcome | 2 | 2021 | 12596 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1012 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2010 | 477 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 972 | 0.060 |
Why?
|
| Combined Modality Therapy | 2 | 2022 | 1239 | 0.060 |
Why?
|
| DNA Damage | 1 | 2010 | 499 | 0.060 |
Why?
|
| Keratins | 1 | 2006 | 51 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 678 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2018 | 574 | 0.060 |
Why?
|
| Serine-Arginine Splicing Factors | 1 | 2025 | 8 | 0.060 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6713 | 0.060 |
Why?
|
| Founder Effect | 1 | 2025 | 34 | 0.060 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 69 | 0.060 |
Why?
|
| Doxorubicin | 2 | 2018 | 288 | 0.050 |
Why?
|
| Algorithms | 2 | 2022 | 1638 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2024 | 25 | 0.050 |
Why?
|
| Introns | 1 | 2025 | 282 | 0.050 |
Why?
|
| Caspase 1 | 1 | 2024 | 45 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2025 | 230 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2024 | 125 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 949 | 0.050 |
Why?
|
| Polyphenols | 1 | 2023 | 22 | 0.050 |
Why?
|
| Haplotypes | 1 | 2025 | 527 | 0.050 |
Why?
|
| Pandemics | 2 | 2021 | 1141 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 2 | 2014 | 377 | 0.050 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2014 | 90 | 0.050 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2023 | 39 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 79 | 0.050 |
Why?
|
| Exons | 1 | 2025 | 759 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2023 | 185 | 0.050 |
Why?
|
| Aged | 2 | 2021 | 20500 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2013 | 167 | 0.050 |
Why?
|
| Skin | 1 | 2025 | 533 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 3711 | 0.050 |
Why?
|
| Mutation | 3 | 2025 | 5953 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2021 | 168 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2021 | 99 | 0.040 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2021 | 162 | 0.040 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2020 | 6 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2020 | 12 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2020 | 16 | 0.040 |
Why?
|
| Chromogranins | 1 | 2020 | 29 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2022 | 348 | 0.040 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2020 | 75 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2025 | 901 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2020 | 67 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 192 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 160 | 0.040 |
Why?
|
| Health Surveys | 1 | 2020 | 258 | 0.040 |
Why?
|
| Urban Population | 1 | 2021 | 276 | 0.040 |
Why?
|
| Prognosis | 2 | 2023 | 4806 | 0.040 |
Why?
|
| Mitochondria | 1 | 2024 | 732 | 0.040 |
Why?
|
| Carya | 1 | 2018 | 1 | 0.040 |
Why?
|
| Pimozide | 1 | 2018 | 7 | 0.040 |
Why?
|
| Hyperprolactinemia | 1 | 2018 | 23 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2018 | 295 | 0.040 |
Why?
|
| Asia | 1 | 2018 | 123 | 0.030 |
Why?
|
| Risperidone | 1 | 2018 | 61 | 0.030 |
Why?
|
| Luminescent Agents | 1 | 2017 | 6 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 448 | 0.030 |
Why?
|
| Osteocytes | 1 | 2017 | 12 | 0.030 |
Why?
|
| Zebrafish | 1 | 2020 | 408 | 0.030 |
Why?
|
| Fishes | 1 | 2017 | 31 | 0.030 |
Why?
|
| Selenium | 1 | 2017 | 15 | 0.030 |
Why?
|
| Life Style | 1 | 2020 | 436 | 0.030 |
Why?
|
| Cities | 1 | 2017 | 49 | 0.030 |
Why?
|
| Intestines | 1 | 2021 | 579 | 0.030 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 116 | 0.030 |
Why?
|
| Biological Availability | 1 | 2017 | 138 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 882 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2012 | 1205 | 0.030 |
Why?
|
| Mental Health | 1 | 2020 | 365 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2022 | 714 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2017 | 72 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 202 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 396 | 0.030 |
Why?
|
| Risk Factors | 2 | 2023 | 10644 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2017 | 204 | 0.030 |
Why?
|
| Logistic Models | 1 | 2020 | 1791 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1610 | 0.030 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2015 | 44 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 576 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 99 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2079 | 0.030 |
Why?
|
| Virus Latency | 1 | 2015 | 61 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 2018 | 373 | 0.030 |
Why?
|
| Virion | 1 | 2015 | 116 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 58 | 0.030 |
Why?
|
| Cell Tracking | 1 | 2014 | 16 | 0.030 |
Why?
|
| Cell Hypoxia | 1 | 2014 | 86 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 21 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 61 | 0.030 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2014 | 39 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2127 | 0.030 |
Why?
|
| Materials Testing | 1 | 2013 | 79 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 110 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1034 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2015 | 325 | 0.030 |
Why?
|
| Heterografts | 1 | 2014 | 190 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 2625 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 132 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2013 | 15 | 0.030 |
Why?
|
| Organosilicon Compounds | 1 | 2013 | 2 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 280 | 0.020 |
Why?
|
| Colloids | 1 | 2013 | 15 | 0.020 |
Why?
|
| Porosity | 1 | 2013 | 42 | 0.020 |
Why?
|
| Caspase 9 | 1 | 2013 | 75 | 0.020 |
Why?
|
| Polypyrimidine Tract-Binding Protein | 1 | 2012 | 9 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 361 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2012 | 23 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 372 | 0.020 |
Why?
|
| Transcription Factor RelA | 1 | 2012 | 49 | 0.020 |
Why?
|
| Phospholipase C gamma | 1 | 2012 | 28 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6265 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2012 | 111 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2013 | 190 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 299 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2014 | 754 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2012 | 142 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2012 | 261 | 0.020 |
Why?
|
| Serine | 1 | 2012 | 160 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 3595 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2012 | 237 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2012 | 579 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 638 | 0.020 |
Why?
|
| RNA Interference | 1 | 2012 | 493 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 3932 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 826 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2010 | 97 | 0.020 |
Why?
|
| Models, Biological | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 1284 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2571 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 843 | 0.020 |
Why?
|
| Keratin-9 | 1 | 2008 | 2 | 0.020 |
Why?
|
| Alpharetrovirus | 1 | 2008 | 4 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2008 | 94 | 0.020 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 95 | 0.020 |
Why?
|
| Glucose | 1 | 2012 | 839 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2889 | 0.020 |
Why?
|
| HIV | 1 | 2008 | 171 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 162 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 979 | 0.010 |
Why?
|